ECJ should uphold Italian enforcer on Roche/Novartis, AG says
Advocate-General Henrik Øe has urged the European Court of Justice to rule in favour of a decision to fine Roche and Novartis for colluding to induce consumers to use a more expensive drug rather than a cheaper off-label alternative, and to confirm the Italian competition enforcer's finding of a by-object restriction of competition.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.